Government and Regulations

Profitably Reining in Health Care Fraud

The Health Care Fraud Prevention and Enforcement Action team is changing how the government fights certain types of fraud.


 

The U.S. Department of Justice (DOJ) and the HHS say joint efforts to combat health care fraud have seen more than $27.8 billion returned to the Medicare Trust Fund. During fiscal year 2014 alone, the Health Care Fraud and Abuse Control (HCFAC) Program recovered $3.3 billion in taxpayer dollars from individuals and companies that attempted to defraud federal health programs, including programs serving seniors, people with disabilities, and those with low incomes.

Related: Fiduciary Services for Veterans With Psychiatric Disabilities

For every dollar spent on health care-related fraud and abuse investigations in the past 3 years, the administration has recovered $7.70—$2 higher than the average return on investment since the HCFAC Program was created in 1997.

Related: Health Care Is Coming to a "Crossing"

The success in recovering money is due to a 2-pronged strategy. First, instead of “pay and chase” efforts targeting fraudsters, the administration implements programs that aim to prevent fraud and abuse in the first place, according to an HHS press release. Second, the Health Care Fraud Prevention and Enforcement Action Team—run jointly by HHS and DOJ—is changing how the government fights certain types of health care fraud. Now, cases are investigated through real-time data analysis, not a prolonged subpoena and account analysis, according to HHS. This means a significantly shorter time between identification of fraud, arrest, and prosecution.

Recommended Reading

On the Scent of Cancer
Federal Practitioner
Putting Research Into Real-Life Practice
Federal Practitioner
HHS Grants Expand Home Visiting
Federal Practitioner
DoD and YMCA Renew Partnership
Federal Practitioner
Understanding the Corporate Data Warehouse
Federal Practitioner
Sharing Alzheimer Research, Faster
Federal Practitioner
Family Support Can Prevent Postdeployment Suicide
Federal Practitioner
Nivolumab Approved for Expanded Indication
Federal Practitioner
Protecting Sensory Health
Federal Practitioner
VHA Under Harsh Criticism From OIG, GAO
Federal Practitioner

Related Articles